Author

Ramanan Gopalan

Observed names: R Gopalan, R. Gopalan

Institution: Dermira (United States)

Observed institution: Dermira (United States)

OpenAlex ID: A5089086135

Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis

2020 · Emma Guttman-Yassky, Andrew Blauvelt, et al. · JAMA Dermatology · 351

Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials

2018 · David M. Pariser, Adelaide A. Hebert, et al. · American Journal of Clinical Dermatology · 43

Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials

2018 · Adelaide A. Hebert, Dee Anna Glaser, et al. · Pediatric Dermatology · 34

Long‐term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44‐week open‐label extension study

2020 · Adelaide A. Hebert, Dee Anna Glaser, et al. · Pediatric Dermatology · 23

Lebrikizumab, a High-Affinity IL-13 Inhibitor, Improves Clinical Manifestations in Moderate-to-Severe Atopic Dermatitis: Primary Results From a Randomized, Double-Blinded, Placebo-Controlled, Dose-Ranging, Phase 2b Study

2019 · E Guttman-Yassky, A Blauvelt, et al. · SKIN The Journal of Cutaneous Medicine · 4

Bayesian Nonparametric Regression: Smoothing Using Gibbs Sampling

1996 · Alaattin Erkanli, Ramanan Gopalan · Dialnet (Universidad de la Rioja) · 4

Short- and Long-Term Efficacy and Safety of Glycopyrronium Cloth for the Treatment of Primary Axillary Hyperhidrosis: Post Hoc Pediatric Subgroup Analyses from the Phase 3 Studies

2018 · Adelaide A Hebert, Dee Anna Glaser, et al. · SKIN The Journal of Cutaneous Medicine · 1

P069 Effect of Lebrikizumab on Lung Function in Patients With Severe Eosinophilic Asthma

2021 · P. Korenblat, E. Sher, et al. · Annals of Allergy Asthma & Immunology

27567 Clinical management of ocular events with topical glycopyrronium tosylate in the treatment of primary axillary hyperhidrosis

2021 · D.A. Glaser, R. Gopalan, et al. · Journal of the American Academy of Dermatology

16428 Lebrikizumab, a high-affinity interleukin-13 inhibitor, improves clinical manifestations in moderate to severe atopic dermatitis: Time course of response from a randomized, double-blinded, placebo-controlled, dose-ranging, phase 2b study

2020 · Emma Guttman-Yassky, Andrew Blauvelt, et al. · Journal of the American Academy of Dermatology

Impact of Lebrikizumab on Patient-Reported Outcomes in Atopic Dermatitis: Prospective and Post Hoc Analyses of a Phase 2b Clinical Trial Demonstrate Clinically Meaningful Improvements

2020 · E Guttman-Yassky, A Blauvelt, et al. · SKIN The Journal of Cutaneous Medicine

Onset of Action With Glycopyrronium Cloth in the Treatment of Primary Axillary Hyperhidrosis

2018 · D Pariser, L Green, et al. · SKIN The Journal of Cutaneous Medicine

Clinical Management of Anticholinergic Adverse Events with Glycopyrronium Cloth, a Treatment for Primary Axillary Hyperhidrosis

2018 · D Pariser, R Gopalan, et al. · SKIN The Journal of Cutaneous Medicine

Works count: 13

Citation count: 460

H-index: 4

I10-index: 4